Pharmaceutical Care Network Europe

The Pharmaceutical Care Network Europe (PCNE) was established in 1994  and it became an official association (under Dutch law) in 2004.
Pharmaceutical Care is the pharmacist's contribution to the care of individuals, in order to optimize medicines use and improve health outcomes.

Conferences Working groups

8th PCNE Working Symposium 2022 , Lisbon, Portugal / hybrid

Navigating research on pharmaceutical care

11-12 February 2022


Welcome 

The 8th PCNE Working Symposium 2022 will be held in Lisbon, Portugal, with a hybrid format, and reunite international pharmacists under the title ‘Navigating research on pharmaceutical care’. Evocating the Portuguese discoveries from the 15th and 16th centuries, when numerous territories and maritime routes were recorded as a result of the intensive maritime exploration, we will be exploring the vast potential for new pharmaceutical services to yield greater results.

Given the unpredictability of these times, we are prepared to deliver the symposium in a hybrid format, in which you will be able to participate in lectures, the oral communications session and the closing session remotely.

We do, however, expect you will be able to join us in-person in Lisbon for a more immersive experience!

Pre-symposium

We will be organizing a Pre-Symposium with 1 workshop and 2 expert courses as a pre-event to the Symposium. The Pre-Symposium will focus on matters relevant to researchers and PhD students in different levels of needs and expectations.

See the tab 'Pre-Symposium' for more information.

 

The Symposium

With 2 keynote lectures and 4 different workshops to choose from, participants will be able to catch up on PCNE work streams and assess new avenues for our research network. We will propose the following topics, from which participants will be able to select 2:

  •   WS1. How to validate a questionnaire (Isabelle Arnet, Christiane Eickhoff)
  •   WS2. The future of Pharmaceutical Care and pharmacy related outcomes research in Europe (Mitja Kos, Kurt Hersberger)
  •   WS3. PCNE DRP-classification: a case of classification or validation cases? (Tommy Westerlund, Ina Richling, Nejc Horvat)
  •   WS4. Grow in guideline implementation: from maturity matrix to indicators (Martina Teichert, Kenji Fujita)

This year, we will launch the Foppe van Mil Memorial Lecture, which is dedicated to the memory of our colleague and friend, whose lifelong dedication on fostering pharmaceutical care research was such an inspiration for many of us.

During the symposium, participants will be able to learn and discuss about new avenues for pharmaceutical care research, but also spend quality time together. Coffee-breaks and meals are great opportunities to network, review or get to know new friends.

 

Ema Paulino, Isabelle Arnet, Martina Teichert, Jacqueline Hugtenburg, Bjarke Abrahamsen, Susanne Kaae, Kurt Hersberger.

 

The PCNE wishes to thank following sponsors for their contributions to the Symposium.

KNMP logo 100 kleur rgb FI Logo2011 RGB Springer
     

Lectures

Foppe van Mil Memorial Lecture

 This year, we will launch the Foppe van Mil Memorial Lecture, which is dedicated to the memory of our colleague and friend, whose lifelong dedication on fostering pharmaceutical care research was such an inspiration for many of us.

 

Prof. Filipa Costa, Portugal  

 The lecture without the testimonials

 

Keynote Lecture: Developing and implementing interventions: from idea to daily practice.

 

Prof. Jacqueline Hugtenburg, the Netherlands   

 The lecture

Workshops on 11th February 10.00-13.00h and 12th February 10.00-13.00h 

WS1: How to validate a questionnaire 

(Isabelle Arnet, Christiane Eickhoff)

 

Patient self-report in the form of questionnaires are cheap, non-invasive, well accepted and easy to implement in daily practice. This is why they are widely used to measure many patient reported outcomes, such as medication (non)adherence.

 

After a questionnaire has been developed and pre-tested, further steps are needed for its validation. However, the validity of a questionnaire can be examined in numerous ways, and many questionnaires have only been incompletely validated. Therefore, it is of utmost importance that researchers are aware of the most common tests of validity. In addition, the translation procedure should be standardized before disseminating validated questionnaires around the globe.

 

In this workshop, participants will learn what stands behind content validity, criterion validity and construct validity. In order to transfer theory into practice, participants are invited to bring their own questionnaire. Use the chance to get an expert feedback! Alternatively, we will use a new tool that was developed during PCNE workshops in 2020 and 2021, the so-called 13-STARS (13-item Screening Tool for AdheRence to medicineS).

 

In case of marked interest, the participants will be offered the possibility to carry out the validation study of the 13-STARS in their own country, given that the translation has been performed according to robust rules. This workshop could be the start for a multicenter study and an international collaboration, under the supervision of the workshop moderators. PhDs are encouraged to discuss and clarify this opportunity beforehand with their supervisors. 

 

In this WS, participants will:

  1. define the validation procedure of questionnaires in general and of a questionnaire brought by the participants or the 13-STARS as an illustrative example, keeping the pharmacy setting in mind;
  2. learn the procedures needed to translate questionnaires from a source language to any target language.

 

In order for participants to refresh some basic knowledge on adherence and questionnaire building, we invite participants to join a zoom meeting Thursday 3 Februar 2022 at 18h (Basel and Berlin time). The link will be distributed shortly before.

 
 

WS2: The future of Pharmaceutical Care and pharmacy related outcomes research in Europe

(Mitja Kos, Kurt Hersberger)

 

Full description

 

In the past, we have seen several developments in the area of Pharmaceutical Care, of which medication review is perhaps one of the most promising. The day-to-day struggle and some success in between makes us confident that we are on the right path. However, research evidence and developments that implement into pharmacy practice from which the patients could actually benefit are not self-evident. In simple terms, do we know how to build research excellence and where to head our developments in order to prolong patients’ life and improve their quality of life? As PCNE is approaching the 30 years of its establishment, it is perhaps time to make a deep reflection and create new opportunities for the decade to come. 

 

 The aim of the workshops is: 

  1. To reflect current Pharmaceutical Care research and achievements in the development of pharmacy practice.
  2. To prepare a research strategy with the potential to achieve excellence in pharmacy practice.
  3. To draft key research projects that could be run in parallel or even have a potential for a joint, international research project. 

 

Workshop Report

 

WS3: PCNE DRP-classification: a case of classification or validation cases?

(Tommy Westerlund, Ina Richling, Nejc Horvat)

 

Over the past four years, the PCNE DRP classification has evolved from version 7 to the current version 9.1. During the validation rounds of the PCNE DRP classification in recent years, it has become apparent that coding inconsistencies originate in unresolved issues with the classification as well as in the insufficiently defined validation cases, which are not fully developed. Moreover, the cases do not cover a wide range of available DRP codes. 

 

During the workshop participants will:

  1. address these classification issues
  2. draw conclusions
  3. improve the content of the existing validation cases or develop new ones.

 

Workshop Report

 

WS4: Grow in guideline implementation: from maturity matrix to indicators 

(Martina Teichert, Kenji Fujita)

 

Earlier a maturity matrix (MM) was developed for primary care organizations to identify and prioritize areas in practice organization for quality improvement.  Following this concept a MM for pharmacies (MM-P) was developed to implement the recommendations of pharmaceutical care guidelines in daily practice.  To this,  five meaningful domains within the pharmacy organization were chosen in one axis of the matrix with five subsequent growth steps in each row.

 

By reasoning from the organizational preconditions, guideline recommendations can be implemented stepwise, matching the situation of an individual pharmacy team.


For instance, growth in different organisational domains is needed to implement care to diabetes patients with impaired renal function that have reduce metformin use at threatening dehydration, based on a complete medication history and actual laboratory measures.To realize this, for instance data storage with actual registration, agreements with the general practitioner on the process and training of the team on how to perform adequate patient consultations are preconditions needed.

 

The systematic organizational growth will improve the scores on Quality Indicators (QI) for patient care. Therefore, this workshop connects with our earlier work on a set of QIs for diabetes patients.

  

During this workshop participants will

  1. Identify relevant domains within pharmacy practice organization to implement pharmaceutical care for diabetes.
  2. Define growth states in the MM-P for pharmaceutical care of diabetes patients within the own situation and compare this to other countries.
  3. Formulate specific measurable, achievable, realistic and time dependent activities to improve organizational preconditions to implement guideline recommendations in pharmaceutical care for diabetes.
  4. Identify QIs (from our earlier specified set of indicators) that would improve by these actions.

 

Workshop Report 4

 

 

Dowload a paper version of the program here

Pre-Symposium Thursday 10th February 2022

12.00-13.00

Registration plus lunch

13.00-17.00

Pre-Symposium (Description, see tab Pre-Symposium)

18.30-19.30

Dinner time

 

Symposium Program Friday 11th February 2022

8.00-8.30

Registration

8.30-9.00 

Opening

9.00-9.45

Foppe van Mil Memorial Lecture

Prof. Filipa Costa, Portugal

9.45-10.00

 Coffee-Break

10.00-13.00 

Workshop Series 1

13.00-14.00

PCNE Soapbox (members only) + Lunch

14.00-15.00

Poster walking tour (poster presentations in groups)

15.00-16.30

Oral Communications

16.30-16.45

Coffee Break

16.45-19.15

PCNE General Assembly (members only)

19.30-23.00

PCNE Social event

 (Separate registration)

 

Symposium Program Saturday 12th February 2022

8.00-9.00

Breakfast

9.00-9.45

Keynote Lecture

9.45-10.00

Coffee Break

10.00-13.00

Workshops series 2 (repeated workshops)

13.00-13.30

Lunch

13.30-14.30

Closing session, incl. poster finals and awards

Abstracts

ABSTRACT SUBMISSION IS NOW CLOSED

 

Abstracts must preferably liaise with the themes of PCNE or the Symposium: Research in Pharmaceutical Care, Drug-related Problems, Medication Review, Adherence, or Indicators and Guidelines.

Abstract submission started on the 1sth November 2021 and ended on the 15th December 2021 at 24.00h CET sharp.

The abstracts with the highest quality as per the evaluation of the Scientific Committee will be selected to be presented at the Oral Communications session with an award for the best oral communication. The other abstracts will be organized in groups and presented as posters. The best posters per group are part of a ‘poster walk’ with a presentation and make chance for the poster award.

Awards are available for the best Oral Communication (the FI Oral Communication Award) and the best poster (the KNMP Best Poster Award).

The organising committee wishes to thank all members who contributed to the review of the abstracts.

Abrahamsen Bjarke, DENMARK

Arnet Isabelle, SWITZERLAND

Da Costa Filipa, PORTUGAL

Eickhoff Christiane; GERMANY

Foulon  Veerle, BELGIUM

Fujita Kenji, JAPAN

Henman Martin, IRL

Hersberger Kurt, SWITZERLAND

Horvath Nejc , SLOVENIA

Hoti Kreshnik, KOSOVO

Hugtenburg Jacqueline, THE NETHERLANDS

Kaae Suzanne, DENMARK

Kaufmann Carole, SWITZERLAND

Kos Mitja, SLOVENIA

Koster Ellen, THE NETHERLANDS

Odalovic Marina, SERBIA

Seidling Hanna, GERMANY

Stämpfli Dominik, SWITZERLAND

Teichert Martina, THE NETHERLANDS

Westerlund Tommy, SWEDEN

List of accepted abstracts (click on the title to see the abstract)

ID Title Scope Organization
494 Understanding risk factors and reasons of non-participation to an interventional study to monitor medication adherence in patients with diabetic kidney disease Adherence Department of Nephrology and Hypertension, Lausanne University Hospital, Lausanne, Switzerland
500 Facilitators and barriers in communicating medication adherence appraisal electronically to physicians Adherence Pharmaceutical Care Research Group, Department of Pharmaceutical Sciences, University of Basel, Switzerland
503 Creating and validating a medication adherence universal questionnaire: The MAUQ Adherence Pharmacology and Pharmaceutical Care Laboratory, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal; Coimbra Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal
509 Integrating a new cardiovascular medicine in daily routine: applying Greenhalgh’s implementation framework to assess patient perspectives. Adherence Utrecht University
512 The ENABLE online repository of medication adherence technologies: interim result of the Delphi study Adherence Deep Digital Phenotyping Research Unit, Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg & University of Luxembourg, Faculty of Science, Technology and Medicine, Luxembourg
513 Medication persistence with and adherence to dipeptidyl peptidase-4 inhibitors among patients with diabetes type II in Slovenia Adherence University of Ljubljana, Faculty of Pharmacy
515 Patterns of Benzodiazepine consumption before and during the COVID-19 pandemic in the Azores archipelago population Adherence CBIOS – Universidade Lusófona’s Research Center for Biosciences & Health Technologies
528 Food instructions on oral anticancer therapy: evidence and impact on clinical practice Adherence KU Leuven
544 Validation of an announced telephone pill count compared to a home-visit pill count in people with type 2 diabetes or cardiovascular disease Adherence Dept General Practice and Elderly CarerdamUMC, location VUmc, Amsterdam, The Netherlands
573 Detection of reasons for excessive use of short-acting β2-agonists (SABA) therapy in asthma: a descriptive study Adherence 1Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands
505 A no-filter snapshot of drug-related problems in Ankara University Hospitals Drug-related Problems Ankara University
520 Potentially Inappropriate Medication prescribing in older adults according to EU(7) PIM list: A Nationalwide study in Portugal Drug-related Problems Research Unit for Inland Development, Polytechnic Institute of Guarda (UDI/IPG), Av. Dr. Francisco Sá Carneiro n°50, 6300-559, Guarda, Portugal.
529 Development of the Estonian medication review documentation system for drug-related problems based on PCNE’s classification v9.0 Drug-related Problems University of Tartu, Institute of Pharmacy; Estonia
534 Evaluation of key questions to identify patients’ difficulties in medication administration Drug-related Problems Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany; Cooperation Unit Clinical Pharmacy, Heidelberg University Hospital, Heidelberg, Germany
539 Perspectives on medication safety from older migrants with cognitive impairment and exposed to polypharmacy and their families Drug-related Problems Migrant Health Clinic, Odense University Hospital
540 Co-creation of an intervention to increase medication safety among vulnerable migrants Drug-related Problems Migrant Health Clinic, Odense University Hospital
541 Health care professionals’ perspectives on medication safety among older migrants with cognitive impairment exposed to polypharmacy Drug-related Problems Migrant Health Clinic, Odense University Hospital
569 Use of the PCNE classification to analyze DRPs associated with the use of antibiotics in caesarean sections Drug-related Problems Universidad de Salamanca
572 Patient-reported sexual adverse drug events on an online platform for medication experiences Drug-related Problems Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands
518 Development of the eHealthResp online course to improve antibiotic prescribing for respiratory tract infections – a two-round Delphi study Indicators and Guidelines iBiMED – Institute of Biomedicine, Department of Medical Sciences, University of Aveiro, Aveiro, Portugal
545 Evaluation of cardiovascular pharmacotherapy guideline compliance and risk factor control in Portuguese community pharmacy patients Indicators and Guidelines Pharmacology and Pharmaceutical Care Laboratory, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal; Coimbra Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal
552 Development of a Maturity Matrix for community pharmacies to implement guideline recommendations: the diabetes care case study. Indicators and Guidelines Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands
489 Key stakeholders’ experiences with the implementation of medication reviews in community pharmacies – a systematic review Medication Review Robert Gordon University, Aberdeen, Scotland
490 Pharmacy owners’ views and experiences with the implementation of medication reviews in German community pharmacies – a qualitative study Medication Review Robert Gordon University, Aberdeen, Scotland
493 Effects of multidisciplinary medication review in geriatric fallers: a patient’s perspective Medication Review Pharmacy, Pharmaceutical Biology&Clinical Pharmacy, Paracelsus Medical University, Salzburg, Austria.
498 Medication review based on electronic medication records and patient clustering: firsts steps to design an algorithm that assists the provision of tailored pharmaceutical services Medication Review Farmácia Central do Cacém, Lisbon, Portugal
506 Pharmacological basis of anticholinergic burden scales and indexes Medication Review Pharmacology and Pharmaceutical Care Laboratory, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal; Coimbra Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal
510 Changes in antihypertensive medications and intensity of antihypertensive treatment at hospital discharge and 30 days afterwards Medication Review University of Ljubljana, Faculty of Pharmacy
517 Impact of pharmacist-led medication reconciliation on healthcare utilisation: a controlled clinical trial Medication Review 2University of Ljubljana, Faculty of Pharmacy, Aškerčeva cesta 7, 1000 Ljubljana, Slovenia
524 Methods to elicit and evaluate the attainment of patient goals in medication optimization interventions for nursing home residents: a scoping review Medication Review KU Leuven
531 Changes in the medication during six months’ participation in the interprofessional medication management programme ARMIN Medication Review ABDA - Federal Union of German Associations of Pharmacists, Department of Medicine
542 Implementation fidelity of a pharmacist-led transitional pharmaceutical care program: process evaluation of the MARCH study Medication Review Dept Clinical Pharmacology and Pharmacy, AmsterdamUMC, location VUmc, Amsterdam, The Netherlands
556 Task sharing in an interprofessional medication management program (ARMIN) – a survey of general practitioners and community pharmacists in Germany Medication Review Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany; Cooperation Unit Clinical Pharmacy, Heidelberg University Hospital, Heidelberg, Germany
557 Prevalence of Potentially Inappropriate Medications, Clinically Relevant Drug Interactions and Anticholinergic Burden among Portuguese institutionalized patients with dementia Medication Review Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), Instituto Universitário Egas Moniz (IUEM), Caparica, Portugal
560 Comparing different information sources in detecting clinically relevant drug interactions in Portuguese institutionalized patients using quetiapine Medication Review Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), Instituto Universitário Egas Moniz (IUEM), Caparica, Portugal
491 Evaluating patterns of prescription of tramadol/dexketoprofen following an alert-based intervention Pharmaceutical Care, other Clinical Pharmacy and Pharmaceutical Care Unit. Department of Pharmacy and Pharmaceutical Technology, and Physical Chemistry. Faculty of Pharmacy and Food Sciences. University of Barcelona. Barcelona, Spain
497 Strengthening medication safety in Danish municipalities Pharmaceutical Care, other Pharmakon, Danish College of Pharmacy Practice
499 Community pharmacists' perceptions on counselling and follow-up of patients using high-protein or hypercaloric food supplements Pharmaceutical Care, other CBIOS – Universidade Lusófona’s Research Center for Biosciences & Health Technologies
502 From pharmacists to pharmacists: how to find a global definition for Pharmacy Service? Pharmaceutical Care, other University of Basel
508 Evaluation of eHealth interventions to improve medication adherence: who is being left behind? Pharmaceutical Care, other Aveiro Healthcare Centre, Aradas Health Unit, Aveiro, Portugal; Faculty of Health Sciences, GRUBI – Systematic Reviews Group, University of Beira Interior, Covilhã, Portugal
523 Information needs and preferences of pharmacy staff regarding safe compounding of medicines during pregnancy and lactation: results from a cross-sectional survey in Belgium Pharmaceutical Care, other KU Leuven – Department of Pharmaceutical and Pharmacological Sciences
525 CAVAsa: Pharmacists’ taking up a role in the detection and referral of patients with (unmet) mental and psychosocial needs Pharmaceutical Care, other Catholic University of Leuven
536 Do clinical pharmacists have access to timely serum creatinine levels to prevent acute kidney injury? Pharmaceutical Care, other Assistant Professor, Faculty of Pharmacy, University of Lisbon
550 Pain severity and its impact: perceived implications on pain management with medications Pharmaceutical Care, other University of Prishtina, Faculty of Medicine Division of Pharmacy, Department of Pharmacy Practice and Pharmaceutical Care
551 Exploring stoicism during self-reporting of pain and its subsequent management with analgesic medication Pharmaceutical Care, other University of Prishtina, Faculty of Medicine Division of Pharmacy, Department of Pharmacy Practice and Pharmaceutical Care, Kosovo
554 Patient-reported use patterns and adverse effects with analgesics – a Danish pharmacy survey Pharmaceutical Care, other University of Southern Denmark
561 ApoForsk – A Danish video blog communicating research of relevance for community pharmacies Pharmaceutical Care, other Odense University Hospital
566 Management of Acute Upper Respiratory Infections during the COVID-19 Pandemic: Challenges for Community Pharmacies Pharmaceutical Care, other Ezfy
567 Preparing future pharmacists to provide effective behaviour change support in pharmaceutical care consultations: early adoption of the Train4Health educational products Pharmaceutical Care, other Nursing School of Lisbon
488 Continuity of care after hospital discharge in type 2 diabetic polymorbid patients Research in Pharmaceutical Care ISPSO, University of Geneva, Switzerland
495 Counseling first hand – understanding the customer and yourself through mentalizing – developing an education for pharmacy workforce to support Patient centered care. Research in Pharmaceutical Care University of Copenhagen; Department of Pharmacy
501 ANTIDEPRESSANTS PRESCRIBING TRENDS 2009 – 2018: A NATIONAL DATABASE STUDY Research in Pharmaceutical Care University of Ljubljana, Faculty of Pharmacy
504 Screening for Patients with Hepatitis C in Swiss Community Pharmacies: a Pilot Study Research in Pharmaceutical Care Pharmaceutical Care Network Switzerland
516 Medication reconciliation at internal medicine wards in Norway Research in Pharmaceutical Care University of Oslo
519 Effect of a pharmacist-led intervention on the quality of drug treatment Research in Pharmaceutical Care University of Oslo
526 Do individuals with chronic diseases perceive conflicting information regarding their medications? Research in Pharmaceutical Care Université de Genève
527 Quality of patient-centered care for patients treated with oral anticancer drugs Research in Pharmaceutical Care KU Leuven
530 Development and psychometric validation of the CONTACT-Patient-Centered Care Questionnaire Research in Pharmaceutical Care KU Leuven
543 Pharmacogenetic testing and consultation in the community pharmacy – development of a new pharmaceutical care service Research in Pharmaceutical Care Pharmaceutical Care Research Group, Department of Pharmaceutical Sciences, University of Basel, Switzerland
548 Recognizing and Addressing Limited Pharmaceutical Literacy (RALPH) interview guide: validation to Spanish language and agreement with the original English version. Research in Pharmaceutical Care Clinical Pharmacy and Pharmaceutical Care Unit, Dept. of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain
565 Medication reconciliation service at hospital discharge: multicentre study in Spanish hospitals and community pharmacies Research in Pharmaceutical Care University of San Jorge
574 Feasibility of the ‘Respiratory Adherence Care Enhancer’ (RACE) instrument in community pharmacies for asthma and COPD patients with maintenance inhaler therapy: study protocol for a feasibility trial Research in Pharmaceutical Care Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands

Courses 10th February 2021  13.00-17.00h

Students who want to register for a student fee, need to send a pdf-copy of their University or College registration card to the PCNE office (info@pcne.org) as attachment to an email.

Workshop 1: Definition of pharmacy-led services

Isabelle Arnet, Selina Barbati and Pascal Baumgartner (Pharmaceutical Care; Basel, Switzerland)

Since two decades, community pharmacists have been moving from traditional medication dispensing activities towards more patient-centered modes of practice. For pharmacists to take an active role in patient health and offer professional services, new skills and knowledge are required. The terminology for these services varies largely in literature from very detailed “cognitive pharmacist-led services” to more elusive “medication management services”.

In this workshop, participants will be confronted to a plethora of terms and definitions retrieved from published literature. We expect participants covering the entire range of academic levels that is, from PhD students to Professor.

Together, they will:

a) determine what they understand by "pharmacy services" in their countries;

b) select the most convenient terms retrieved from the literature;

c) generate a first definition as draft.

 

Workshop Report 

 

Expert course 2: An introduction to pharmacy communication research

Susanne Kaae & Ellen Koster (Denmark)

Aim:

The expert course will introduce participants to recent pharmacy communication research projects as the starting point for:

a) providing an overview of investigated themes and topics within pharmacy communication research

b) providing an overview of relevant designs and methods in pharmacy communication research

c) describing challenges when conducting communication studies in pharmacy practice

The workshop will include short lectures with examples of pharmacy communication research combined with reflection exercises and group assignments to define ideas about what would be a relevant research question in pharmacy communication that participants would like to study in practice and possible challenges therein. These discussions will lead to a specification of project ideas, different types of solutions to overcome identified challenges, resulting in guidance for starting a new project in pharmacy communication.

Aims:

Based on participants’ own interest and experiences with pharmacy communication research the expert course will create an awareness of:

1)    aspects to consider when starting up/ continuing pharmacy communication projects 

2)    discuss what could/ should be the role of PCNE within pharmacy communication research 

Homework before workshop:

Think of a topic or relevant question you would like to answer/study in your practice?

 

Expert Course 2

 

Expert Course 3: How to write a successful grant

Jacqueline Hugtenburg (The Netherlands), Mara Guerreiro (Portugal)

Academics need the skills to write winning grant applications to conduct research sustainably and maximise the societal benefit of science. Writing a good grant application is challenging but is a skill that can be perfected.

Real life examples will be presented and practical exercises in small groups will be performed, drawing attention to key issues, such as how to meet eligibility criteria and guidelines of the funding body.

This course will be delivered by researchers with an established track record in leading successful grant applications and is intended to help those less experienced in grant writing, to increase their likelihood of being funded. 

 

Expert Course 3 

 

The conference will be held in a seaside hotel, Sesimbra Hotel and Spa, in Sesimbra, Portugal. Sesimbra is approx. 40 km from Lisbon.

We are arranging for shuttles from the airport to the venue, but you can also take a taxi, which would cost you around 40,00€.

sesimbra hotel spa.jpeg

 

Conference venue

Sesimbra Hotel & Spa,
Rua Navegador Rodrigues Soromenho 
2970-773 Sesimbra
Portugal

Web: https://www.sesimbrahotelspa.com/pt

Contact

For all information, please contact the PCNE office at info@pcne.org.

Picturebook